Zevra Therapeutics, Inc. (ZVRA)
8.46
-0.12
(-1.40%)
USD |
NASDAQ |
Dec 10, 16:00
8.57
+0.11
(+1.30%)
After-Hours: 17:16
Zevra Therapeutics Market Cap: 476.28M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 997.81M |
| XOMA Royalty Corp. | 425.61M |
| Akebia Therapeutics, Inc. | 431.22M |
| NovaBay Pharmaceuticals, Inc. | 302.43M |
| Palatin Technologies, Inc. | 25.25M |
Market Cap Related Metrics
| PE Ratio | 13.41 |
| PS Ratio | 5.476 |
| Price to Book Value | 3.577 |
| Price | 8.46 |
| Earnings Yield | 7.46% |
| Normalized PE Ratio | 5.916 |